SOX2 and melanoma: Furthermore, treatment with PLX4032 was more effective in reducing the clonogenic ability of SOX2-depleted melanoma cells (LV-shSOX2), whereas the clonogenic growth of SOX2 WT (LV-c) cells was only moderately affected by treatment with PLX4032 at the same doses (Fig. 5G).